PPARG and central nervous system cancer: In several diseases, such as gliomas, neurodegenerative diseases, amyotrophic lateral sclerosis, and multiple sclerosis, the Wnt/β-catenin pathway acts in an opposite way of peroxisome proliferator-activated receptor gamma (PPARγ) [21].